Kathryn A. Gold, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses current unmet needs in squamous cell carcinoma of the lung.
Kathryn Gold, MD, UC San Diego Health
Advertisement
Articles by Kathryn Gold, MD, UC San Diego Health
Advertisement
Latest Updated Articles
Background of Small Cell Lung CancerPublished: December 11th 2020 | Updated:
First-Line Approach for Treating Extensive-Stage Small Cell Lung CancerPublished: December 11th 2020 | Updated:
Results from the CASPIAN Trial for Extensive-Stage Small Cell Lung CancerPublished: December 11th 2020 | Updated:
Differentiating Small Cell Lung Cancer and Non-Small Cell Lung CancerPublished: December 11th 2020 | Updated:
Rationale for I/O therapy in Extensive-Stage Small Cell Lung CancerPublished: December 11th 2020 | Updated:
Advances in Extensive-Stage Small Cell Lung CancerPublished: December 11th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5